Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase NA 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 3Vomiting 2Neoplasms 2Nausea 2Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia 2Hodgkin Disease 2Thalassemia 1Teratoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Osteosarcoma 1Neoplasms, Germ Cell and Embryonal 1Medulloblastoma 1Lymphoma, Follicular 1Hepatoblastoma 1Hematologic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Methotrexate 3Ifosfamide 3Cisplatin 3Magnetic Resonance Spectroscopy 2Leucovorin 2Electroacupuncture 2Doxorubicin 2sargramostim 1regorafenib 1delta 24-sterol reductase 1apatinib 1Tissue and Organ Procurement 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Resistance Training 1Radiotherapy, Image-Guided 1Proton Therapy 1Positron Emission Tomography Computed Tomography 1Physical Therapy Modalities 1Pentetic Acid 1Palliative Care 1Nutritional Support 1Neuropsychological Tests 1Neoadjuvant Therapy 1Minocycline 1Mesna 1Heparin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Glutamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Osteosarcoma × Mesna × Clear all
NCT00673179 2014-09-10

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

M.D. Anderson Cancer Center

Phase NA Terminated
7 enrolled 3 charts
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡